Yujie Dong1, Butian Zhang2, Qi Yang3, Jiajing Zhu2, Xiaojie Sun4. 1. Department of Emergency, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China. 2. Department of Radiology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China. 3. Department of Obstetrics and Gynecology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China. 4. Department of Plastic and Reconstruction Surgery, China-Japan Union Hospital of Jilin University, No. 126 Xiantai Street, Changchun, 130033, Jilin, China. sunxiaojie5413@sina.com.
Abstract
OBJECTIVE: We conducted this updated meta-analysis to evaluate the effects of PRP in patients with knee or hip OA. METHOD: PubMed, Embase, and Web of Science were searched to identify randomized controlled trials (RCTs) that compared the efficacy of PRP with other intra-articular injections. The outcomes of interest included Western Ontario and McMaster (WOMAC), Knee Injury and Osteoarthritis Outcome Score (KOOS), Visual Analog Scale (VAS), Harris Hip Score (HHS), and International Knee Documentation Committee (IKDC). RESULTS: Twenty-four RCTs with 21 at knee OA and three at hip OA were included in this meta-analysis. The PRP injections significantly improved the WOMAC score, VAS score, IKDC score, and HHS score as compared with comparators. The WOMAC pain, stiffness, and physical function scores were also significantly better in the PRP group than in the control group. Most of the evaluated parameters that favored PRP were observed in knee OA but not in hip OA, at short-term (at 1, 2, 3, 6, 12 months) but not long-term follow-up (at 18 months), in RCTs with low risk of bias. CONCLUSIONS: Intra-articular PRP injection provided better effects than other injections for OA patients, especially in knee OA patients, in terms of pain reduction and function improvement at short-term follow-up. Key Points • This updated meta-analysis, based on great sample size and high-quality studies, evaluates the effects of PRP in patients with knee or hip OA. • Intra-articular PRP injection provided better effects than other injections for OA patients. • Most of the evaluated parameters that favored PRP were observed in knee OA at short term (at 1, 2, 3, 6, 12 months).
OBJECTIVE: We conducted this updated meta-analysis to evaluate the effects of PRP in patients with knee or hip OA. METHOD: PubMed, Embase, and Web of Science were searched to identify randomized controlled trials (RCTs) that compared the efficacy of PRP with other intra-articular injections. The outcomes of interest included Western Ontario and McMaster (WOMAC), Knee Injury and Osteoarthritis Outcome Score (KOOS), Visual Analog Scale (VAS), Harris Hip Score (HHS), and International Knee Documentation Committee (IKDC). RESULTS: Twenty-four RCTs with 21 at knee OA and three at hip OA were included in this meta-analysis. The PRP injections significantly improved the WOMAC score, VAS score, IKDC score, and HHS score as compared with comparators. The WOMAC pain, stiffness, and physical function scores were also significantly better in the PRP group than in the control group. Most of the evaluated parameters that favored PRP were observed in knee OA but not in hip OA, at short-term (at 1, 2, 3, 6, 12 months) but not long-term follow-up (at 18 months), in RCTs with low risk of bias. CONCLUSIONS: Intra-articular PRP injection provided better effects than other injections for OA patients, especially in knee OA patients, in terms of pain reduction and function improvement at short-term follow-up. Key Points • This updated meta-analysis, based on great sample size and high-quality studies, evaluates the effects of PRP in patients with knee or hip OA. • Intra-articular PRP injection provided better effects than other injections for OA patients. • Most of the evaluated parameters that favored PRP were observed in knee OA at short term (at 1, 2, 3, 6, 12 months).
Entities:
Keywords:
Hip osteoarthritis; Knee osteoarthritis; Platelet-rich plasma
Authors: John Richmond; David Hunter; James Irrgang; Morgan H Jones; Lynn Snyder-Mackler; Daniel Van Durme; Cheryl Rubin; Elizabeth G Matzkin; Robert G Marx; Bruce A Levy; William C Watters; Michael J Goldberg; Michael Keith; Robert H Haralson; Charles M Turkelson; Janet L Wies; Sara Anderson; Kevin Boyer; Patrick Sluka; Justin St Andre; Richard McGowan Journal: J Bone Joint Surg Am Date: 2010-04 Impact factor: 5.284
Authors: Kirk A Campbell; Bryan M Saltzman; Randy Mascarenhas; M Michael Khair; Nikhil N Verma; Bernard R Bach; Brian J Cole Journal: Arthroscopy Date: 2015-05-29 Impact factor: 4.772
Authors: Carlos J Meheux; Patrick C McCulloch; David M Lintner; Kevin E Varner; Joshua D Harris Journal: Arthroscopy Date: 2015-10-01 Impact factor: 4.772
Authors: Reva C Lawrence; David T Felson; Charles G Helmick; Lesley M Arnold; Hyon Choi; Richard A Deyo; Sherine Gabriel; Rosemarie Hirsch; Marc C Hochberg; Gene G Hunder; Joanne M Jordan; Jeffrey N Katz; Hilal Maradit Kremers; Frederick Wolfe Journal: Arthritis Rheum Date: 2008-01
Authors: Timothy E Foster; Brian L Puskas; Bert R Mandelbaum; Michael B Gerhardt; Scott A Rodeo Journal: Am J Sports Med Date: 2009-11 Impact factor: 6.202
Authors: Fabio Cerza; Stefano Carnì; Alessandro Carcangiu; Igino Di Vavo; Valerio Schiavilla; Andrea Pecora; Giuseppe De Biasi; Michele Ciuffreda Journal: Am J Sports Med Date: 2012-10-25 Impact factor: 6.202
Authors: Sebastián Cruz Rodriguez-García; Raul Castellanos-Moreira; Jacqueline Uson; Esperanza Naredo; Terence W O'Neill; Michael Doherty; Mikael Boesen; Hemant Pandit; Ingrid Möller Parera; Valentina Vardanyan; Lene Terslev; Will Uwe Kampen; Maria Antonieta D'Agostino; Francis Berenbaum; Elena Nikiphorou; Irene Pitsillidou; Jenny de la Torre-Aboki; Loreto Carmona Journal: RMD Open Date: 2021-06
Authors: Liam D A Paget; Gustaaf Reurink; Robert-Jan de Vos; Adam Weir; Maarten H Moen; Sita M A Bierma-Zeinstra; Sjoerd A S Stufkens; Gino M M J Kerkhoffs; Johannes L Tol Journal: JAMA Date: 2021-10-26 Impact factor: 56.272